back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2025-12-15 15:28 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,400,000 | |
| Older filings | ||||||
| Filed 2025-12-10 17:21 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
||
| Filed 2025-12-11 16:42 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-11 16:39 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2025-12-11 16:33 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
||
| Filed 2025-12-11 16:28 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-11 14:37 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
450,000 | |
| Filed 2025-12-10 17:21 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,400,000 | |
| Filed 2025-09-22 10:05 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-02-04 15:08 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,000,000 | |
| Filed 2025-02-03 16:16 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
250,000 | |
| Filed 2024-12-26 14:39 Tx date 2024-12-19 |
$DTC
Defence Therapeutics Inc. |
Theodorou, Elias
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-11-18 12:12 Tx date 2024-11-08 |
$DTC
Defence Therapeutics Inc. |
Selivanova, Svetlana
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-11-18 12:09 Tx date 2024-11-08 |
$DTC
Defence Therapeutics Inc. |
Selivanova, Svetlana
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-15 16:43 Tx date 2024-11-15 |
$DTC
Defence Therapeutics Inc. |
Cesarone, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-285.00
-500 vol $0.57 each |
115,500 | |
| Filed 2024-10-01 17:35 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2024-10-01 17:34 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-30 13:21 Tx date 2024-09-27 |
$DTC
Defence Therapeutics Inc. |
De, Arnab
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-06-10 12:53 Tx date 2024-06-07 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Meagher Consulting Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,849
+2,500 vol $1.14 each |
9,100 | |
| Filed 2024-05-30 22:48 Tx date 2024-05-29 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Meagher Consulting Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,449
+3,000 vol $1.15 each |
6,600 | |